THE IMPACT OF OMEGA-3 FATTY ACIDS COMBINED WITH INITIAL PERIODONTAL THERAPY ON SALIVARY VISFATIN AND TNF-Α LEVELS IN CHRONIC PERIODONTITIS PATIENTS | ||||
| Egyptian Dental Journal | ||||
| Article 3, Volume 63, Issue 2 - April (Oral Medicine, X-Ray, Oral Biology & Oral Pathology), April 2017, Page 1437-1447 PDF (653.68 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/edj.2017.74541 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Hesham M. El-Sharkawy; Samah H. Elmeadawy | ||||
| Associate Professor of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University. | ||||
| Abstract | ||||
| Recent investigations have demonstrated the positive therapeutic effects of omega-3 polyunsaturated fatty acids (PUFAs) on several chronic inflammatory diseases such as rheumatoid arthritis, chronic inflammatory bowel diseases and periodontitis. The objective of the present study was to evaluate the impact of omega-3 PUFAs in conjunction with initial periodontal therapy (IPT) on periodontal clinical parameters and salivary markers in patients with chronic periodontitis. Thirty four systemically healthy individuals with advanced chronic periodontitis were enrolled and randomly assigned into two groups. The control group (IPT, n=17) was treated with IPT alone whereas the test group (IPT+omega-3, n=17) was treated with IPT and daily dietary supplementation of omega-3 PUFAs (in the form of 2 grams of fish oil capsules per day) for three months. Clinical parameters were recorded at baseline and 3 months following therapy for both groups. Saliva samples were collected at the same time points and analyzed for visfatin and tumor necrosis factor-α (TNF-α). After 3 months, clinical periodontal parameters of advanced chronic periodontitis were significantly improved in both groups. The omega-3 group showed significant greater pocket depth (PD) reduction and clinical attachment (CAL) gain compared to the control group after therapy. Salivary TNF-α levels showed a statistically significant decrease in the omega-3 group at 3 months compared to the control group. Salivary visfatin levels were reduced significantly at 3 months in both groups without any significant variation. It was concluded that dietary supplementation with omega-3 PUFAs could be a potential viable adjunct to IPT that significantly improves all periodontal parameters and reduces salivary visfatin and TNF-α levels in advanced chronic periodontitis. Interestingly, salivary visfatin could be a useful periodontal biomarker to monitor responses to periodontal therapy. | ||||
| Keywords | ||||
| omega-3 fatty acids; initial periodontal therapy; Chronic Periodontitis; Visfatin; saliva | ||||
|
Statistics Article View: 182 PDF Download: 278 |
||||
